‘How I knew I had endometrial cancer’: Survivors share their stories - UT MD Anderson
‘How I knew I had endometrial cancer’: Survivors share their stories UT MD Anderson
Uterine (endometrial) Cancer News
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer - Newsroom | UCLA
Universal, ready-to-use immunotherapy detects and destroys endometrial cancer Newsroom | UCLA
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments - Roswell Park Comprehensive Cancer Center
JAMA Review by Roswell Park Experts Details Rising Endometrial Cancer Rates, Impact of New Precision Treatments Roswell Park Comprehensive Cancer Center
Endometrial Cancer Staging Updates Reflect Molecular Profiling - Cleveland Clinic
Endometrial Cancer Staging Updates Reflect Molecular Profiling Cleveland Clinic
A new test could transform endometrial cancer diagnosis - ABC News - Breaking News, Latest News and Videos
A new test could transform endometrial cancer diagnosis ABC News - Breaking News, Latest News and Videos
Endometrial cancer is rising among older women, minorities | Moves in Medicine - 6abc Philadelphia
Endometrial cancer is rising among older women, minorities | Moves in Medicine 6abc Philadelphia
Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer - Inside Precision Medicine
Antibody-Drug Conjugate Shows Activity in Hard-to-Treat Uterine Cancer Inside Precision Medicine
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma - The ASCO Post
Case 3: Newly Diagnosed Advanced Uterine Papillary Serous Carcinoma The ASCO Post
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily
Vaginal swabs provide "sufficient signal" to detect endometrial cancer, study finds - Contemporary OB/GYN
Vaginal swabs provide "sufficient signal" to detect endometrial cancer, study finds Contemporary OB/GYN
Focus on: Endometrial Cancer – Health Information Library - PeaceHealth
Focus on: Endometrial Cancer – Health Information Library PeaceHealth
Signs of endometrial cancer you shouldn’t ignore - Geisinger Health
Signs of endometrial cancer you shouldn’t ignore Geisinger Health
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma - Nature
Dual PI3K/AKT/mTOR and CDK4/6 inhibition suppresses survivin to overcome uterine dedifferentiated endometrial carcinoma Nature
Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma | Cancer Communications - Science Partner Journals
Multiplexed CRISPR/Cas9 Editing of Tumor Suppressor Genes in the Mouse Endometrium Recapitulates High-Risk Endometrial Carcinoma | Cancer Communications Science Partner Journals
Vaginal Swab Detects Molecular Signals for Endometrial Cancer - Clinical Lab Products
Vaginal Swab Detects Molecular Signals for Endometrial Cancer Clinical Lab Products
6 Tips for Going Through Endometrial Cancer Treatment - Cleveland Clinic Health Essentials
6 Tips for Going Through Endometrial Cancer Treatment Cleveland Clinic Health Essentials
DCS-NET: a multi-task model for uterine ROI detection and automatic staging of early endometrial cancer in MRI - Nature
DCS-NET: a multi-task model for uterine ROI detection and automatic staging of early endometrial cancer in MRI Nature
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? - The ASCO Post
Low-Risk Endometrial Cancer: Does a Lack of Adjuvant Therapy Affect Survival? The ASCO Post
Can PCOS lead to uterine cancer? - Roswell Park Comprehensive Cancer Center
Can PCOS lead to uterine cancer? Roswell Park Comprehensive Cancer Center
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial - Nature
Mirvetuximab soravtansine plus pembrolizumab in recurrent folate receptor alpha-positive uterine serous carcinoma: a phase II trial Nature
Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments - Yale School of Medicine
Genetic Study of Rare Endometrial Cancer Uncovers Potential Treatments Yale School of Medicine
Endometrial Cancer Remission Rate: What Patients Need to Know in 2025 - Oncodaily
Endometrial Cancer Remission Rate: What Patients Need to Know in 2025 Oncodaily
Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report - Cureus
Neoadjuvant Chemotherapy Followed by Radical Cytoreductive Surgery in Serous Endometrial Carcinoma With Inguinal Lymph Node Metastasis: A Case Report Cureus
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library - Wiley
Acta Obstetricia et Gynecologica Scandinavica | NFOG Women's Health Journal | Wiley Online Library Wiley
The 4 Stages of Uterine Cancer—and What Each One Means - Health: Trusted and Empathetic Health and Wellness Information
The 4 Stages of Uterine Cancer—and What Each One Means Health: Trusted and Empathetic Health and Wellness Information
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models - Cure Today
CAR-NKT Immunotherapy Eliminates Endometrial Tumors in Preclinical Models Cure Today
More Good News for GLP-1 Agonists and Cancer Risk - MedPage Today
More Good News for GLP-1 Agonists and Cancer Risk MedPage Today
Tamoxifen induces PI3K activation in uterine cancer - Nature
Tamoxifen induces PI3K activation in uterine cancer Nature
Evaluating Radiotheranostic Targets for Endometrial Cancer - Journal of Nuclear Medicine
Evaluating Radiotheranostic Targets for Endometrial Cancer Journal of Nuclear Medicine
A STEM educator battles rare endometrial cancer - UT Physicians
A STEM educator battles rare endometrial cancer UT Physicians
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia - 2 Minute Medicine
Glucagon-like peptide-1 receptor agonists may reduce endometrial cancer risk in endometrial hyperplasia 2 Minute Medicine
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update - Lawsuit Information Center
Hair Relaxer Lawsuit Settlement | June 2026 Litigation Update Lawsuit Information Center
‘Don’t be embarrassed’: Omaha survivor, doctor warn of rising endometrial cancer rates, urge symptom awareness - WOWT
‘Don’t be embarrassed’: Omaha survivor, doctor warn of rising endometrial cancer rates, urge symptom awareness WOWT
Uterine Cancer: Unveiling the Unseen & Urgent Need - AstraZeneca
Uterine Cancer: Unveiling the Unseen & Urgent Need AstraZeneca
Utepreva launches FDA-cleared endometrial sampler to support endometrial cancer detection - Contemporary OB/GYN
Utepreva launches FDA-cleared endometrial sampler to support endometrial cancer detection Contemporary OB/GYN
Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer - Frontiers
Emerging drug delivery approach using nanomaterials for the treatment of endometrial cancer Frontiers
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer - University of Miami
Sylvester Comprehensive Cancer Center Launches Clinical Trial on Fasting for Endometrial Cancer University of Miami
Early-Stage Endometrial Carcinoma After Renal Transplantation: Emphasizing Multidisciplinary Surgical Management - Wiley Online Library
Early-Stage Endometrial Carcinoma After Renal Transplantation: Emphasizing Multidisciplinary Surgical Management Wiley Online Library
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer - PR Newswire
New Survey Data Exploring Patient Experiences with Endometrial Cancer Care Presented at 2026 Society of Gynecologic Oncology (SGO) Annual Meeting on Women's Cancer PR Newswire
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer - Dana-Farber Cancer Institute
Dana-Farber Research Uncovers Potential Targeted Therapy for Endometrial Cancer Dana-Farber Cancer Institute